P ositron emission tomography (PET) is a highly sensitive, quantitative, noninvasive imaging technique, and therefore is one of the most popular imaging modalities for disease diagnosis and monitoring of therapeutic effects 1 . The 18 F-radionuclide contributes greatly to the success of this imaging method and is often preferred for PET imaging due to its wide availability, favorable half-life (109.8 min), high isotopic purity, and low positron energy (640 keV), allowing sequential acquisition of PET images with a relatively high resolution 2 . However, to synthesize 18 F-labeled PET tracers, traditional labeling methods are mostly based on carbon-fluorine bond formation, which usually demands multiple steps and/or harsh reaction conditions such as heating at high temperatures in organic media 3 . Moreover, most 18 F-radiolabeling reactions require strict anhydrous conditions due to the limited reactivity of the fluoride anion as a nucleophile in aqueous solution 4 (Fig. 1a ). Feasible and efficient 18 F-labeling methods in physiological media remain highly desirable for the introduction of 18 F into useful biomolecules, such as watersoluble peptides and antibodies that bind to overexpressed receptors in various inflammatory tissues and tumors 2 .
A few studies [5] [6] [7] [8] reported that fluorinase enzyme can catalyze the incorporation of 18 F into PET radiotracers under aqueous conditions. However, the high substrate specificity severely limits the scope of application for this enzyme method 7 . Several direct aqueous 18 F-labeling approaches have been reported, using organofluorosilicons 2, [9] [10] [11] [12] [13] [14] [15] , aluminum complexes [16] [17] [18] [19] or trifluoroborates 20-28 as non-carbon fluoride acceptors to afford one-step labeling of peptides. These non-macroelement fluoride acceptor-based methods exploit their Lewis acid characteristics. Lewis acid promoters, such as SnCl 4 and AlCl 3 , are sometimes required to activate the fluorine-element bond to facilitate [ 18 F]Fī ncorporation in these systems 29 . The high bond enthalpy and low activation energy for the binding of Si, Al, and B with F − lead to the formation of stable bonds with 18/19 F − instead of being attacked by and bonded with OH −30 .
However, these methods still pose obvious drawbacks: (i) limited stability and high lipophilicity of the organosiliconbased 18 F-labeling blocks; (ii) specific pH requirement for trifluoroborate-based 18 F-labeling; (iii) steric effect of bulky Al-18 F-based chelate synthons; and iv) potential biosafety issue due to possible metal contamination in the final product. Recently, a bulky [GaF 3 (BnMe 2 -tacn)], another metal chelate system, was labeled in aqueous solutions by 18 F/ 19 F isotopic exchange but showing slight defluorination of the 18 F-labeled product in plasma 29 . Collectively, non-solvent-biased 18 F-labeling methods with macroelement-composed fluoride acceptors remain unexplored.
The phosphorus (P) element is essential for life and phosphines are components of deoxyribonucleic acid, ribonucleic acid, adenosine triphosphate, and phospholipids 31 . The formation heat of phosphine fluoride radicals is −12.5 ± 5 kcal mol −1 while those of silicon fluoride, boron fluoride, and fluorocarbon radicals are −4.8 ± 3, −27.7 ± 3.3, and 61.0 ± 2 kcal mol −1 , respectively 32 . Therefore, phosphorus, boron, and silicon readily form more stable products with fluorine (compared to fluorocarbon). Phosphorus is strongly fluorophilic based on previous reports 33, 34 . For example, the affinity of F-P in PF 5 (380 kJ mol −1 ) is even higher than that in F-B in BF 3 (346 kJ mol −1 ). Preparation of compounds containing the P-18 F bond was demonstrated by 18 F-labeling of phospho-pesticide 35 and NCH-PF 5 33 in organic solvents under heating condition.
Here we rationally design and develop organophosphine precursors that allow for easy synthesis and efficient radiolabeling with high radiochemical yields (RCYs) and molar activities under mild conditions. In this way, 18 F-labeled biomolecules are successfully obtained in either organic solvents or aqueous media with high RCY up to 100% within 15 min, as shown in Fig. 1b . Proof-of-concept of 18 F-labeling with heat/solvent-sensitive biomolecules in one step is demonstrated by biomolecular tracers include 18 F-labeled human serum albumin (HSA) for blood pool imaging and 18 F-labeled c(RGDyk) which targets the integrin α v β 3 receptor of the U87MG cell (glioblastoma). Thus, the method reported here permits non-specialist-manageable rapid 18 F-labeling of extensive biomolecules and their use in PET imaging.
Results
Mechanism of rapid H 2 O-resistant 18 F/ 19 F exchange. We first performed computational density functional theory (DFT) calculations to simulate the F/F isotope exchange processes on the organophosphine fluoride acceptors with substitutions of varying steric hindrance. Using the B3LYP method [36] [37] [38] [39] [40] , two-step addition-elimination pathways for both F/F isotope exchange and the competing OH/F substitution (i.e., hydrolysis) were identified for Fig. 2 . Such a mechanistic path suggests an inversion of the tetravalent phosphorus after a single F/F exchange. Hence, the overall reactions are not strictly free energy neutral but negligible. The OH/F exchange processes share similar reaction pathways with the exception that [F…H 2 O] − binds with the phosphorus center using its oxygen atom in the first addition step.
The calculated free energy profiles show that the pentacoordinate intermediates are unstable compared to the initial materials for both F/F isotope exchange and OH/F substitution. A comparison of the relative stabilities of TS1-X and TS2-X (X = 1-5) to those of TSO1-X and TSO2-X shows that the free energy barriers for the F/F exchange processes were distinctly lower than the corresponding values for the OH/F substitution. The differences in relative free energy values between TS1-X and TSO1-X for the 1-5 reaction systems were −3.6, −4.1, −5.1, −7.2, and −4.7 kcal mol −1 , respectively, while those between TS2-X and TSO2-X for the five reaction systems were −5.9, −7.8, −7.1, −8.1, and −4.4 kcal mol −1 , respectively. These results strongly indicate that the F/F isotope exchange is kinetically more favorable than the corresponding OH/F substitution for all of the reactant systems. According to the calculated relative free energies of the transition states, the predicted rates for F/F isotope exchange follow the order of 1 ≈ 2 > 5 > 4 > 3. In addition, the OH/F substitution processes exhibit endothermic free energy values (e.g., ΔG = 2.3-5.1 kcal mol −1 ), suggesting that these processes are neither spontaneous nor thermodynamically favorable. Overall, the DFT calculations demonstrate that the 18 F/ 19 F isotope exchange occurs automatically rather than the competing OH/F substitution in terms of both kinetics and thermodynamics ( Table 1) .
Synthesis of organofluorophosphine fluoride acceptors. Next, the designed organofluorophosphine fluoride acceptors were prepared via oxidative coupling between various hydrophosphine oxide and F − . Specifically, dibutylphosphinic fluoride (1), diphenylphosphinic fluoride (2), tert-butyl(phenyl)phosphinic fluoride (3) and benzyl 2-(tert-butylfluorophosphoryl)-2methylpropanoate (4) were synthesized from phosphine oxides using the Reformatsky-type reaction 41 , followed by copperpromoted fluorination of phosphine 42 . Compound 1 was found to be difficult to obtain and only 19 F and 31 P NMR spectra were obtained because of its volatility and low yield.
Radiochemistry. For radiolabeling tests, [ 18 F]F − solution unloaded from a cyclotron target was diluted and added to reaction vials pre-charged with the organofluorophosphine fluoride acceptors. Rapid 18 F-labeling was achieved in high RCYs by 18 
Relative Gibbs free energies in kcal mol -1 F/F exchange reaction pathway 6.5 6.7 13.9 12.6 11.1 6.5 6.7 11. (Table 1) . During a metabolic stability examination, [ 18 F]4 remained 100% intact at 2 h post-injection and was more stable than [ 18 F]3, which is in good agreement with the predictions from the free energy barrier calculations (Table 1) . MicroPET/CT imaging with [ 18 F]4 in healthy ICR mice was then performed to investigate the in vivo metabolic process. No increase in bone uptake was observed up to 120 min post-injection. The radioactivity was primarily concentrated in the bladder and gallbladder over time (see Supplementary Figure 7 ). 2,3,5,6-Tetrafluorophenyl 2-(tert-butylfluorophosphoryl)-2-methylpropanoate (DBPOF-COOC 6 HF 4 , 5), a derivative with an activated ester, was synthesized and conjugated to several peptide ligands of clinical interest 43, 44 to obtain one-step-labeling precursors.
Radiosynthesis of 18 F-DBPOF-c(RGDyk) and PET imaging.
Using a manual labeling procedure, 18 F-DBPOF-c(RGDyk) as a peptide ligand was prepared at an average RCY (the amount of activity in the final product expressed as the percentage of starting activity) of >30% in 25 min with >98% purity after purification with a C-18 solid-phase extraction cartridge. In order to obtain cGMP compliant 18 F-DBPOF-c(RGDyk), we established an automated procedure using a commercial multifunction radiosynthesis module PET-MF-2V-IT-I (Beijing PET Technology, China). The schematic layout of the automated synthesis module is shown in Supplementary Figure 4 . Quality control analysis protocols were established according to the United States Pharmacopeia guidelines for PET radiopharmaceuticals. Average RCY (the amount of activity in the final product expressed as the percentage of starting activity) was 15-25% for the automated procedure. The radiochemical purity of 18 F-DBPOF-c(RGDyk) was confirmed to be >95% by radio-HPLC analysis. The molar activity was measured to be 0.06-0.13 Ci μmol −1 for the product prepared using the automated module, compared to 0.006-0.01 Ci μmol −1 for the manually prepared product. MicroPET/CT imaging data, shown in Fig. 3a , indicated an uptake of 18 F-DBPOF-c(RGDyk) with standardized uptake value (SUV) of 0.76 in U87MG gliomablastoma, and a target to non-target ratio of 2.4. No obvious signal was detected in the tumor as illustrated in the inset image of Fig. 3a , demonstrating that the specific uptake was blocked by DBPOF-c(RGDyk).
Radiosynthesis of 18 F-DBPOF-HAS and PET imaging.
Human serum albumin (HSA, 66.5 kDa) is a heat-sensitive globular protein that exhibits high solubility and stability with a plasma half-life of 16-18 h 45 . DBPOF-HSA was prepared by simple conjugation of DBPOF-COOC 6 HF 4 to HAS within 30 min. By manual 18 F-labeling, the RCY (the amount of activity in the final product expressed as the percentage of starting activity) of 18 F-DBPOF-HSA was >5% with molar activity of~0.03 Ci μmol −1 in shorter synthesis time than other radiofluorination strategies.
PET imaging of healthy female Wistar rats was conducted 1 h after intravenous injection of 18 F-DBPOF-HSA. A whole-body PET/CT of a healthy rat 1 h after 18 F-DBPOF-HSA injection through tail vein is demonstrated in Fig. 3c . The heart ventricles the and the peripheral blood vessels are clearly revealed. Other organs can be also observed but with lower activity concentrations than that in the central vessels. Analysis of 18 F-DBPOF-HSA biodistribution in rats showed high retention in blood with SUVs of 2.4 ± 0.6, 1.4 ± 0.7, and 1.0 ± 0.1 at 0.2, 0.5, and 1 h, respectively. The tissue uptake from the microPET/CT experiments agreed well with the biodistribution results at matched time points. These results indicated that the introduction of DBPOF synthon into HSA and subsequent radiolabeling did not affect the structural or functional integrity of HSA.
Discussion
Biomolecules, such as proteins, carbohydrates, and nucleic acids, are excellent vectors for monitoring physiological and biochemical lesions via PET imaging due to their high affinity and high specificity for many pathogenic targets 46 as well as superior biocompatibility. Most of these vectors are soluble and remain intact in water alone or mixed aqueous solvents rather than in organic solvents, while anionic [ 18 F]F − , with its high solvation energy, becomes inactive in the same solvents. Consequently, the ARTICLE direct incorporation of 18 F is challenging, especially in the case of temperature-, pH-and solvent-sensitive macromolecules. Fortunately, efficient aqueous labeling approaches are theoretically feasible by employing highly fluorophilic fluoride acceptors with very low activation energy and high hydrolysis energy for selective fluoro-substitution. Indeed, fluorophosphine fluoride acceptors have been shown to undergo rapid radiofluorination reaction in at least partially aqueous media 10 .
Theoretical DFT calculations confirmed that the F/F exchange of organophosphines is more favorable both kinetically and thermodynamically than the OH/F exchange, which is consistent with our experimental findings. The detailed reaction mechanisms and free energy variations were illustrated for the organophosphine labels with five representative reactants. In our calculations, the 1:1 hydrogen-bond complex of H 2 O with F − (F − ·H 2 O) was modeled as a nucleophile to account for the solvation effect of water. Nucleophilic substitution at the tetravalent phosphorus center may occur via either a concerted pathway or a stepwise addition-elimination pathway. The latter method involves a pentavalent adduct intermediate owing to the addition of a nucleophile without the loss of a leaving group.
In addition to the spontaneity and aqueous tolerance of these radiolabeling reactions, the compact prothesis configuration and favorable in vivo behavior of the resulting PET tracers are also important. [ 18 F]2 was found to be unstable at pH 7.4-7.6 in human serum, saline, and ethanol because the steric hindrance of benzene is relatively small. In contrast, [ 18 F]3 and [ 18 F]4 exhibited remarkable thermal and hydrolytic stability. The stabilities of 18 F-labeled fluorodiphenylphosphines are consistent with the steric parameters of these compounds, i.e., greater steric hindrance leads to better stability. By virtue of their small size, zero net charge, and negligible decomposition, the physicochemical properties of the 18 F-labeled tracers prepared via the organophosphine fluoride acceptors are similar to those of the unlabeled analogs.
Phosphorus compounds are used in many modern homogeneous catalyst systems because the P-X bonds are thermally robust in general and unlikely to break down by transition metals at the catalysis conditions 47 . Fluorophosphines with bulky or electron-withdrawing substituents, such as (C 6 F 5 ) 2 PF, (CF 3 ) 2 PF, and tBu 2 PF, are also found to be thermally stable [48] [49] [50] [51] . Synthesis and screening of more fluorophosphine fluoride acceptors with various leaving groups are continuing in our laboratories.
In summary, we have developed a procedure for the radiolabeling of a series of organofluorophosphine biomolecules using 18 F-fluoride. Low activation energy is required for the formation of these P-F bonds in comparison to P-OH bonds. As a result, 18 F-labeling can be performed in aqueous media and high radiochemical yields achieved even at room temperature, and acceptable molar activities that are critical for targeted imaging 52 . This inexpensive, rapid, one-step 18 F-radiolabeling procedure holds great promise for widespread applications in radiopharmaceutical industry to produce a variety of biomolecules as potential PET tracers.
